Integrase Inhibitor Prescribing Disparities in the DC and Johns Hopkins HIV Cohorts.
Integrase Inhibitor Prescribing Disparities in the DC and Johns Hopkins HIV Cohorts.
复制标题
DOI:
10.1093/ofid/ofab338
复制
发表时间:
2021-08
影响因子:
4.2
通讯作者:
DC Cohort Executive Committee
中科院分区:
文献类型:
--
作者:
Monroe AK;Levy ME;Greenberg AE;Keruly JC;Moore RD;Horberg MA;Kulie P;Mohanraj BS;Kumar PN;Castel AD;DC Cohort Executive Committee
Integrase inhibitors (INSTIs) are recommended by expert panels as initial therapy for people with HIV. Because there can be disparities in prescribing and uptake of novel and/or recommended therapies, this analysis assessed potential INSTI prescribing disparities using a combined data set from the Johns Hopkins HIV Clinical Cohort and the DC Cohort. We performed multivariable logistic regression to identify factors associated with ever being prescribed an INSTI. Disparities were noted, including clinic location, age, and being transgender. Identifying disparities may allow clinicians to focus their attention on these individuals and ensure that therapy decisions are grounded in valid clinical reasons. We assessed INSTI prescribing disparities using Johns Hopkins HIV Clinical Cohort/DC Cohort data. Disparities were noted, including clinic location, age, and being transgender. Clinicians should focus their attention on these individuals and make therapy decisions grounded in valid clinical reasons.
登录
查看更多内容
影响因子:
1.6
作者:
Jacobson K;Ogbuagu O
通讯作者:
Ogbuagu O
影响因子:
3.7
作者:
Messiaen P;Wensing AM;Fun A;Nijhuis M;Brusselaers N;Vandekerckhove L
通讯作者:
Vandekerckhove L
影响因子:
6.4
作者:
Meditz, Amie L.;MaWhinney, Samantha;Connick, Elizabeth
通讯作者:
Connick, Elizabeth
影响因子:
8.5
作者:
Castel, Amanda D.;Terzian, Arpi;Greenberg, Alan
通讯作者:
Greenberg, Alan
影响因子:
3.8
作者:
Sevelius, Jae M.;Patouhas, Enzo;Keatley, JoAnne G.;Johnson, Mallory O.
通讯作者:
Johnson, Mallory O.